Hall 407
ESMO Colloquium
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Location
Hall 407
Chairs
- Marina C. Garassino
- Ross A. Soo
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
ESMO Colloquium
Introduction
Lecture Time
12:45 PM - 12:50 PM
Session Name
Speakers
- Ross A. Soo
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
- Ross A. Soo
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
ESMO Colloquium
Immune-Check Points Inhibitors (ICI) in non-oncogenic addicted mNSCLC
Lecture Time
12:50 PM - 01:15 PM
Session Name
Speakers
- Marina C. Garassino
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
- Marina C. Garassino
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
ESMO Colloquium
EGFR mutant mNSCLC: Single agent or in combination?
Lecture Time
01:15 PM - 01:40 PM
Session Name
Speakers
- Fabrice Barlesi
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
- Fabrice Barlesi
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
ESMO Colloquium
Future development for the use of biomarkers
Lecture Time
01:40 PM - 02:05 PM
Session Name
Speakers
- Ross A. Soo
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
- Ross A. Soo
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
ESMO Colloquium
Conclusion
Lecture Time
02:05 PM - 02:10 PM
Session Name
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM